Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
18
Report
Login to post
- Valerie Archibald·2025-08-16Novo is clearly the winner in the obesity race. All numbers are superior of any competitors, yet they are traded at forward P/E at 11-12. What a steal.LikeReport
- Enid Bertha·2025-08-16This stock is not to be sold in short term… new all time high will happen in 12-18 months…. That’s on the cardsLikeReport
- Ron Anne·2025-08-15Lock in some gains if NVO hits new highs soon.LikeReport
- Wade Shaw·2025-08-15What’s making you so confident in NVO’s patience payoff?LikeReport
- Porter Harry·2025-08-15Agree with you. Maybe it is near the reversal point.LikeReport
